Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Autoimmune responses to amyloid structures of Abeta(25-35) peptide and human lysozyme in the serum of patients with progressive Alzheimer's disease.

Gruden MA, Davudova TB, Malisauskas M, Zamotin VV, Sewell RD, Voskresenskaya NI, Kostanyan IA, Sherstnev VV, Morozova-Roche LA.

Dement Geriatr Cogn Disord. 2004;18(2):165-71. Epub 2004 Jun 21.

PMID:
15211072
2.

The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model.

Ostrovskaya RU, Gruden MA, Bobkova NA, Sewell RD, Gudasheva TA, Samokhin AN, Seredinin SB, Noppe W, Sherstnev VV, Morozova-Roche LA.

J Psychopharmacol. 2007 Aug;21(6):611-9. Epub 2006 Nov 8.

PMID:
17092975
3.

Increased levels of antigen-bound β-amyloid autoantibodies in serum and cerebrospinal fluid of Alzheimer's disease patients.

Maftei M, Thurm F, Schnack C, Tumani H, Otto M, Elbert T, Kolassa IT, Przybylski M, Manea M, von Arnim CA.

PLoS One. 2013 Jul 18;8(7):e68996. doi: 10.1371/journal.pone.0068996. Print 2013.

4.

Active Aβ vaccination fails to enhance amyloid clearance in a mouse model of Alzheimer's disease with Aβ42-driven pathology.

Nemirovsky A, Shapiro J, Baron R, Kompaniets A, Monsonego A.

J Neuroimmunol. 2012 Jun 15;247(1-2):95-9. doi: 10.1016/j.jneuroim.2012.03.017. Epub 2012 Apr 10.

PMID:
22498096
5.

Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias.

Maetzler W, Berg D, Synofzik M, Brockmann K, Godau J, Melms A, Gasser T, Hörnig S, Langkamp M.

J Alzheimers Dis. 2011;26(1):171-9. doi: 10.3233/JAD-2011-110221.

PMID:
21593566
6.

Beta-amyloid auto-antibodies are reduced in Alzheimer's disease.

Qu BX, Gong Y, Moore C, Fu M, German DC, Chang LY, Rosenberg R, Diaz-Arrastia R.

J Neuroimmunol. 2014 Sep 15;274(1-2):168-73. doi: 10.1016/j.jneuroim.2014.06.017. Epub 2014 Jun 27.

7.

Plasma antibodies to Abeta40 and Abeta42 in patients with Alzheimer's disease and normal controls.

Xu W, Kawarabayashi T, Matsubara E, Deguchi K, Murakami T, Harigaya Y, Ikeda M, Amari M, Kuwano R, Abe K, Shoji M.

Brain Res. 2008 Jul 11;1219:169-79. doi: 10.1016/j.brainres.2008.02.060. Epub 2008 Mar 4.

PMID:
18534566
8.

Increased Number of Plasma B Cells Producing Autoantibodies Against Aβ42 Protofibrils in Alzheimer's Disease.

Söllvander S, Ekholm-Pettersson F, Brundin RM, Westman G, Kilander L, Paulie S, Lannfelt L, Sehlin D.

J Alzheimers Dis. 2015;48(1):63-72. doi: 10.3233/JAD-150236.

9.

Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease.

Weiner HL, Lemere CA, Maron R, Spooner ET, Grenfell TJ, Mori C, Issazadeh S, Hancock WW, Selkoe DJ.

Ann Neurol. 2000 Oct;48(4):567-79.

PMID:
11026440
10.

Autoantibodies to beta-amyloid and neurotransmitters in patients with Alzheimer's disease and senile dementia of the Alzheimer type.

Myagkova MA, Gavrilova SI, Lermontova NN, Kalyn YB, Selezneva ND, Zharikov GA, Kolykhalov IV, Abramenko TV, Serkova TP, Bachurin SO.

Bull Exp Biol Med. 2001 Feb;131(2):127-9.

PMID:
11391392
11.

Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Aβ in plasma of patients with Alzheimer's disease.

Marcello A, Wirths O, Schneider-Axmann T, Degerman-Gunnarsson M, Lannfelt L, Bayer TA.

Neurobiol Aging. 2011 Aug;32(8):1379-87. doi: 10.1016/j.neurobiolaging.2009.08.011. Epub 2009 Sep 24.

PMID:
19781815
12.

Low avidity and level of serum anti-Aβ antibodies in patients with cerebral amyloid angiopathy-related cerebral hemorrhage.

Cao Z, Lv J, Quan W.

Int J Neurosci. 2010 Dec;120(12):760-4. doi: 10.3109/00207454.2010.520379. Epub 2010 Oct 18.

PMID:
20954837
13.
14.

Modified immunotherapies against Alzheimer's disease: toward safer and effective amyloid clearance.

Wang YJ, Zhou HD, Zhou XF.

J Alzheimers Dis. 2010;21(4):1065-75. Review.

PMID:
21504118
15.

Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides.

Mruthinti S, Buccafusco JJ, Hill WD, Waller JL, Jackson TW, Zamrini EY, Schade RF.

Neurobiol Aging. 2004 Sep;25(8):1023-32.

PMID:
15212827
16.

Detection of Amyloid-beta aggregates in body fluids: a suitable method for early diagnosis of Alzheimer's disease?

Funke SA, Birkmann E, Willbold D.

Curr Alzheimer Res. 2009 Jun;6(3):285-9. Review.

PMID:
19519310
17.

Cholinesterase inhibitor use is associated with increased plasma levels of anti-Aβ 1-42 antibodies in Alzheimer's disease patients.

Conti E, Galimberti G, Tremolizzo L, Masetto A, Cereda D, Zanchi C, Piazza F, Casati M, Isella V, Appollonio I, Ferrarese C.

Neurosci Lett. 2010 Dec 17;486(3):193-6. doi: 10.1016/j.neulet.2010.09.050. Epub 2010 Oct 1.

PMID:
20869427
18.

Naturally occurring autoantibodies against beta-amyloid: investigating their role in transgenic animal and in vitro models of Alzheimer's disease.

Dodel R, Balakrishnan K, Keyvani K, Deuster O, Neff F, Andrei-Selmer LC, Röskam S, Stüer C, Al-Abed Y, Noelker C, Balzer-Geldsetzer M, Oertel W, Du Y, Bacher M.

J Neurosci. 2011 Apr 13;31(15):5847-54. doi: 10.1523/JNEUROSCI.4401-10.2011.

19.

Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia: autoantibodies to Abeta((25-35)) oligomers, S100b and neurotransmitters.

Gruden MA, Davidova TB, Malisauskas M, Sewell RD, Voskresenskaya NI, Wilhelm K, Elistratova EI, Sherstnev VV, Morozova-Roche LA.

J Neuroimmunol. 2007 May;186(1-2):181-92. Epub 2007 May 2.

PMID:
17477976
20.

Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.

Boche D, Zotova E, Weller RO, Love S, Neal JW, Pickering RM, Wilkinson D, Holmes C, Nicoll JA.

Brain. 2008 Dec;131(Pt 12):3299-310. doi: 10.1093/brain/awn261. Epub 2008 Oct 25.

PMID:
18953056

Supplemental Content

Support Center